Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |